A variety of movement disorders are known to occur in association with
carbamazepine (CBZ) therapy in adults and children, but development o
f tics has been described infrequently and only in patients with under
lying Tourette's syndrome or other movement disorders. We report 3 chi
ldren with epilepsy who developed facial motor tics after initiation o
f CBZ for complex partial seizures. All 3 had documented CBZ blood lev
els in the therapeutic range at the time, and none had other symptoms
or signs of clinical intoxication. Neurologic examinations were normal
in 2 and showed developmental delay of expressive language in the thi
rd. Brain imaging was normal in all. After development of the tics in
2, CBZ was continued at the same or higher dose, and the tics abated a
nd then ceased spontaneously less-than-or-equal-to 6 months. In the th
ird child, the tics ceased after CBZ discontinuation. These cases demo
nstrate that CBZ can induce simple motor tics in children. These idios
yncratic reactions may be transient and do not always necessitate drug
discontinuation.